Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
Pune, India, October 6th, 2026, FinanceWire This is a paid advertisement. Quantum BioPharma Ltd.
Quantum Biopharma Ltd. (QNTM)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
2 Quantum Computing ETFs Analysts Expect to Outperform in 2027
Quantum computing is becoming one of the next big areas in tech, and ETFs give investors a simple way to gain exposure in 2027. The TipRanks ETF Co...
3 Quantum Computing ETFs With Up to 59% Upside Potential, According to Analysts
Quantum computing remains a high-risk but fast-developing area of tech, with recent industry forecasts pointing to strong growth as the technology ...
2 Quantum Computing ETFs That Could Climb 44%+, Say Analysts
Quantum computing is moving closer to real-world use, giving investors more ways to gain exposure to the sector’s growth. For investors looking bey...
3 Quantum Computing ETFs with Over 23% Upside Potential, According to Analysts
Quantum computing is expected to become one of the next major growth areas in technology as governments and companies increase investment in the fi...